Irinotecan Sucrosofate

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Platinum-Resistant Fallopian Tube Carcinoma

Drug Information

Target Indication

Platinum-Resistant Fallopian Tube Carcinoma

Clinical Trial

Last updated: 8/19/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

IPN.PA

Ipsen S.A.

Related Pipeline

Diarrhea

Primary Biliary Cholangitis (PBC)

Gastroenteropancreatic Neuroendocrine Tumor

Moderate to Severe Glabellar Lines

Alagille Syndrome

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts